My Top Energy Stock for May 2026 and Beyond

Cameco is positioned to benefit from a global nuclear renaissance: 75 reactors are under construction and 120 more are planned worldwide, while uranium prices are up 26.3% to $86/lb. The company reported 2025 revenue growth of 11%, EPS growth of 246%, a 16.93% net margin, and a low 0.14 debt-to-equity ratio, alongside a $1.9 billion India supply deal for 22 million pounds of uranium ore from 2027 to 2035. The article argues geopolitical uncertainty and rising nuclear demand should support Cameco over the next several years.

Analysis

The market is starting to price nuclear as a strategic commodity, not just an ESG consolation prize. That changes the buyer base: utility procurement, sovereign stockpiling, and data-center power planning can all step in as marginal demand, which should support long-duration contracts and reduce spot-price sensitivity for the best assets. In that setup, the real edge goes to producers with tier-1 ore bodies and downstream conversion/fuel exposure, because they capture both scarcity rent and more stable cash conversion than pure miners.

CCJ stands out because its earnings power is increasingly a function of supply discipline rather than just uranium beta. The second-order effect is that if higher prices persist, lower-grade or higher-cost producers will be forced to lean into hedging or defer output, tightening the market further and improving contracting power for the top Western supplier. The overlooked angle is Westinghouse: reactor buildout is a multi-year capex cycle, so the equity can rerate on visible backlog growth even before incremental pounds are physically delivered.

The main risk is that nuclear enthusiasm is being pulled forward by geopolitics faster than the permitting, labor, and financing ecosystem can absorb it. If reactor restarts slip or project schedules in India/Europe/US get delayed by 12-24 months, uranium sentiment can cool sharply even if the long-term story remains intact. A sharper risk is policy-driven supply response from Kazakhstan, Namibia, or Canada, which would cap spot upside and compress the near-term equity multiple.

Consensus seems to be underestimating how sticky uranium pricing can become once utilities re-enter the market after a period of under-contracting. The move may still be early rather than crowded, but the trade is no longer pure commodity convexity; it is a differentiated industrial infrastructure bet with geopolitical duration. That makes CCJ a higher-quality way to express the theme than the broader energy complex, especially if power prices stay volatile and AI-driven load growth keeps improving the demand backdrop.

Key Decisions for Investors

• Long CCJ on a 6-12 month horizon: favor entries on pullbacks because the stock should reprice with each new long-term contract announcement; target asymmetric upside if uranium stays above ~$80/lb, with tighter downside than junior miners due to balance-sheet quality and downstream exposure.
• Buy CCJ Jan-2027 call spreads to express multi-year nuclear capex without taking full spot-commodity risk; this is the cleanest way to monetize reactor buildout optionality while limiting decay if project timelines slip.
• Pair trade: long CCJ / short a basket of higher-cost uranium names or broad energy ETFs over 3-6 months; if the thesis is supply scarcity plus contracting power, the best ore bodies should outperform commodity beta names as margins widen.
• Add BAM only as a small relative-value sleeve, not a standalone thematic long; Westinghouse optionality matters, but the cleaner exposure remains CCJ, and BAM is less directly levered to uranium price or contract renewal momentum.
• Avoid chasing the move in spot uranium proxies after sharp geopolitical spikes; wait for contract announcements or reactor-finance catalysts to confirm that the demand response is structural rather than a 1-2 quarter sentiment trade.